Shanghai ZJ Bio-Tech Co Ltd Class A 688317
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ¥16.08
- Day Range
- ¥16.30–18.50
- 52-Week Range
- ¥12.58–24.06
- Bid/Ask
- ¥18.20 / ¥18.21
- Market Cap
- ¥3.50 Bil
- Volume/Avg
- 8.7 Mil / 2.6 Mil
Key Statistics
- Price/Earnings (Normalized)
- 49.63
- Price/Sales
- 15.80
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Shanghai ZJ Bio-Tech Co Ltd is engaged in research and development, production and sales of genetic diagnostic reagents and instruments and equipment. The rapid real-time fluorescent PCR diagnostic test reagents developed by the company are mainly used in clinical medicine, public health emergencies, entry-exit inspection and quarantine, food inspection, animal husbandry, aquaculture and other fields.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 305
- Website
- https://www.liferiver.com.cn
Comparables
Valuation
|
Metric
|
688317
|
688468
|
300482
|
|---|---|---|---|
Price/Earnings (Normalized) | 49.63 | 21.05 | 26.45 |
Price/Book Value | 0.93 | 2.05 | 2.32 |
Price/Sales | 15.80 | 6.16 | 4.18 |
Price/Cash Flow | 23.12 | 14.42 | 14.74 |
Price/Earnings
688317
688468
300482
Financial Strength
|
Metric
|
688317
|
688468
|
300482
|
|---|---|---|---|
Quick Ratio | 17.04 | 4.71 | 5.59 |
Current Ratio | 18.60 | 5.48 | 7.49 |
Interest Coverage | −811.76 | 111.54 | 18.41 |
Quick Ratio
688317
688468
300482
Profitability
|
Metric
|
688317
|
688468
|
300482
|
|---|---|---|---|
Return on Assets (Normalized) | −3.78% | 7.46% | 7.29% |
Return on Equity (Normalized) | −4.01% | 9.59% | 9.26% |
Return on Invested Capital (Normalized) | −6.37% | 7.98% | 7.99% |
Return on Assets
688317
688468
300482
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Bjjvjbbd | Zgcwcw | $196.0 Bil | |||
| Stryker Corp
SYK
| Nvsrshrq | Zhj | $133.8 Bil | |||
| Boston Scientific Corp
BSX
| Bhcspkyl | Ytgqqr | $124.5 Bil | |||
| Medtronic PLC
MDT
| Kwfhvgdb | Bmgcnj | $113.2 Bil | |||
| Edwards Lifesciences Corp
EW
| Wltcdjnqj | Pjblcn | $39.5 Bil | |||
| Koninklijke Philips NV ADR
PHG
| Xkd | Ddcy | $30.2 Bil | |||
| DexCom Inc
DXCM
| Jwqcdstwm | Wtgh | $27.3 Bil | |||
| Steris PLC
STE
| Xljmsqw | Kkpzbr | $22.8 Bil | |||
| Zimmer Biomet Holdings Inc
ZBH
| Kygclgpqs | Hlmv | $21.3 Bil | |||
| Insulet Corp
PODD
| Bfmbkynj | Jxbkbp | $16.1 Bil |
United States